Tilray

TLRY

Market cap $1.13B

The cannabis industry is set to reach new horizons in 2026. More companies are coming together to take the industry to a level yet to be seen. With bigger and better partnerships taking effect this year, consumer demand should go beyond mere satisfaction. Along with the political climate around cannabis in the US, marijuana stocks could see a jump from all of the above. 2026 brings in a large amount of positive speculation with all that is going on.

TLRY posts record Q2 revenues of $217.5M as international cannabis and distribution strength outweighs beverage headwinds.

Tilray Brands posts record Q2 revenue of $217.5M, beats sales estimates, reaffirms EBITDA outlook as international cannabis and distribution offset beverage weakness.

Tilray reported financial performance for Q2-2026 with international sales driving growth. Tilray remains undervalued after its reverse split and after the rally over rescheduling subsided. Tilray foresees continued synergies from international sales through 2026 and its is positioned for entry into US cannabis markets.

Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by the president's edict.

Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript

Tilray reported Q2 2026 financial results after the bell today. The company reported improvements at the top and bottom of the income statement compared to the same period last year.

Tilray Brands, Inc.. (NASDAQ: TLRY) shares climbed in Thursday's extended trading after the company released its second-quarter earnings report, beating expectations on the top and bottom lines.

International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock New Market Opportunity for Tilray Medical Expansion into the U.S. Strong Financial Position with $292 Million in Cash and Marketable Securities 1 and ~$30 Million Net Cash NEW YORK and LONDON and LEAMINGTON, Ontario, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today reported financial results for its second fiscal quarter ended November 30, 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

Weekly Jobless Claims Come in Muted.